U.S. Baby Infant Formula Market is Booming and Predicted to Hit $6,973.7 million by 2032, With Factors For The Market Growth

Rise in number of women participation in labor force and high nutritional content of infant formula drive the growth of the U.S. baby infant formula market. The U.S. baby infant formula market size was valued at $3,962.7 million in 2022 and is projected to reach $6,973.7 million by 2032, registering a CAGR of 5.7% from 2023 to 2032.

Click Here For Instant PDF: https://www.alliedmarketresearch.com/request-sample/11214

Breastfeeding is not always possible for working moms; hence, baby formula serves as a viable substitute for newborns as its composition is similar to that of breast milk. Nucleotides are components of infant formulae that are required for metabolic functions such as the breakdown of energy and enzymatic reactions. These nucleotides serve as the building blocks for DNA and RNA, which are required for regular physiological activities. Furthermore, iron-rich infant formula aids in the prevention of anemia

Leading Key Players

Players operating in the U.S. baby infant formula market Opportunities and developmental strategies to expand their U.S. baby infant formula market share, increase profitability, and remain competitive in the market. Key players profiled in this report include Abbott Laboratories, Arla Foods amba, Aussie Bubs, Bobbie, Danone S.A., Dana Dairy Group Ltd., ByHeart, Else Nutrition Holdings, Inc., Holle Baby Foods AG, Kabrita USA, Nature's One, LLC, Nestle S.A., Reckitt Benckiser Group LTD., and The Hain Celestial Group, Inc.

Rise in number of women participation in labor force and high nutritional content of infant formula drive the growth of the U.S. baby infant formula market. However, government initiatives to promote breastfeeding and concerns regarding food safety hinder the market growth. On the contrary, preference toward organic baby food & drinks, extensive research on prebiotics and probiotics in baby food, and developments in technology resulting in emergence of new products are expected to open lucrative opportunities for the market players in the future.

Talk to our Analyst: https://www.alliedmarketresearch.com/connect-to-analyst/11214

By distribution channel, the pharmacy/medical stores segment is estimated to register the highest CAGR of 6.6% during the forecast period, due to unawareness about the ingredients in infant formula and issues related to baby food safety. However, the hypermarkets segment held the largest share in 2019, contributing to nearly one-third of the U.S. baby infant formula market, owing to strong economic growth, increase in disposable income, change in demographic profile, and consumer inclination toward infant health.

In line with their own dietary preferences and lifestyle choices, many parents look for natural and organic products for their children. Parents now find it easier to learn about the benefits of organic and natural infant formula products and to spread that knowledge to others due to increase in penetration of social media and online communities. This has boosted demand and raised interest in these products. The trend toward organic and natural infant formula products is therefore likely to persist as more parents become aware of the benefits of these products and as companies continue to develop brand-new, innovative products to meet the escalating demand.

A federally funded nutrition assistance program called Women, Infants, and Children (WIC) helps low-income pregnant and breastfeeding women as well as their infants and young children. The program offers support for breastfeeding, access to nutritious food, and education about nutrition. These initiatives, therefore, tend to decrease the dependency of parents on baby infant formula products, which notably restrain the U.S. baby infant formula market growth

Make a Direct Purchase: https://www.alliedmarketresearch.com/checkout-final/b980420896a233192f07351b288605e0

By point of sale, the OTC segment held the largest share in 2019, accounting for more than two-thirds of the U.S. baby infant formula market, as most of the babies are hypoallergenic and require no special attention with the consumption of infant formula. However, the prescription-based segment is estimated to register the highest CAGR of 6.4% during the forecast period, owing to the unawareness regarding the ingredients and their health effects.

Key finding of the study

In 2022, on the basis of type, the infant milk is segment was the highest contributor to the U.S. baby infant formula industry, in terms of value.

According to the U.S. baby infant formula market analysis, on the basis of ingredients, carbohydrate segment generated the highest revenue in 2022, and is likely to grow at a CAGR of 5.6% during the forecast period.

According to the U.S. baby infant formula market trends, on the basis of distribution channel, the hypermarkets segment garnered the highest revenue in 2022, and is estimated to grow at a CAGR of 5.2% during the forecast period.

According to the U.S. baby infant formula market demand, on the basis of source, the regular segment was the major revenue contributor in 2022, and is estimated to grow at a CAGR of 5.0% during the U.S. baby infant formula market forecast period.

Check out more related studies published by AMR Research:

Infant Nutrition Market - https://www.prnewswire.com/news-releases/infant-nutrition-market-to-reach-61-6-bn-globally-by-2026-at-7-7-cagr-allied-market-research-301107444.html

Asia-Pacific Baby Infant Formula Market - https://www.globenewswire.com/en/news-release/2020/03/17/2001989/0/en/Asia-Pacific-Baby-Infant-Formula-Market-to-reach-26-8-billion-by-2026-Says-Allied-Market-Research.html

Baby Drinks Market - https://www.globenewswire.com/en/news-release/2022/03/14/2402706/0/en/Global-Baby-Drinks-Market-to-Generate-67-10-Billion-by-2031-Allied-Market-Research.html

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.